Peter Libby: Inflammation and Traditional Risk Factors Work Together in Cardiovascular Disease
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, reposted from International Atherosclerosis Society on LinkedIn:
”Informative new vignettes about Inflammation and Cardiovascular Disease. Inflammation and traditional risk factors work together!
The title echoes a paper I did a few years ago: Strandberg TE, Libby P, Kovanen PT. A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy? Cardiovasc Pharmacol 2021;7(3):238-241. ”
Qutoing International Atherosclerosis Society‘s post:
”It’s Inflammation Monday!
Every Monday, IAS will be highlighting the recordings of the live lectures from the Inflammation Academy, held in Madrid on August 28, 2025.
For the first lecture highlight, hear from Peter Libby, MD, as he speaks on how inflammatory mechanisms link traditional risk factors to adverse cardiovascular events.
Watch to learn more.”
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100
-
Jul 23, 2026, 19:11Jecko Thachil: Chlorosis May Have Represented Iron Deficiency in the 19th Century
-
Jul 23, 2026, 15:58Mel Snyder: Beyond Sickle Cell Disease to the Future of Pediatric Genetics
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology